These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37015743)

  • 21. SARS-CoV-2 seroprevalence at urban and rural sites in Kaduna State, Nigeria, during October/November 2021, immediately prior to detection of the Omicron variant.
    Chechet GD; Kwaga JKP; Yahaya J; Noyes H; MacLeod A; Adamson WE
    Int J Epidemiol; 2022 Oct; 51(5):1361-1370. PubMed ID: 35771662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Seroprevalence in Florida Department of Health in Palm Beach County Obstetric Clinics: A Cross-Sectional Study during the First Pandemic Surge.
    Gonik CO; Alonso AM; Gonik B
    Am J Perinatol; 2023 Jun; 40(8):912-916. PubMed ID: 34758496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
    Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
    Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
    Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
    Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron.
    O'Brien SF; Caffrey N; Yi QL; Pambrun C; Drews SJ
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Antibody Prevalence in the Portuguese Municipality of Vila Nova de Gaia after the First Wave of the Pandemic.
    De Carvalho Á; Virgolino A; Queirós P; Henriques AR; Canhão H; Rodrigues AM; Barbosa V; Rodrigues J; Germano de Sousa J; Guimarães M
    Acta Med Port; 2022 Jun; 35(6):468-475. PubMed ID: 36279518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    McClymont E; Albert AY; Alton GD; Boucoiran I; Castillo E; Fell DB; Kuret V; Poliquin V; Reeve T; Scott H; Sprague AE; Carson G; Cassell K; Crane J; Elwood C; Joynt C; Murphy P; Murphy-Kaulbeck L; Saunders S; Shah P; Snelgrove JW; van Schalkwyk J; Yudin MH; Money D;
    JAMA; 2022 May; 327(20):1983-1991. PubMed ID: 35499852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
    Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
    Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.
    Goldfarb DM; Mâsse LC; Watts AW; Hutchison SM; Muttucomaroe L; Bosman ES; Barakauskas VE; Choi A; Dhillon N; Irvine MA; Reicherz F; O'Reilly C; Sediqi S; Xu RY; Razzaghian HR; Sadarangani M; Coombs D; O'Brien SF; Lavoie PM
    BMJ Open; 2022 Apr; 12(4):e057846. PubMed ID: 35383082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
    Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
    JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
    Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
    Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.
    Bolotin S; Tran V; Deeks SL; Peci A; Brown KA; Buchan SA; Ogbulafor K; Ramoutar T; Nguyen M; Thakkar R; DelaCruz R; Mustfa R; Maregmen J; Woods O; Krasna T; Cronin K; Osman S; Joh E; Allen VG
    Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.